| REVIEW ARTICLE |
|
| Year : 2015 | Volume
: 60
| Issue : 3 | Page : 230-237 |
|
|
Treatment of refractory chronic urticaria
Aayushi Mehta, Kiran Godse, Sharmila Patil, Nitin Nadkarni, Manjyot Gautam
Department of Dermatology, Dr. DY Patil Medical College and Hospital, Nerul, Navi Mumbai, Maharashtra, India
Correspondence Address:
Kiran Godse
Department of Dermatology, D.Y. Patil Medical College and Hospital, Nerul, Navi Mumbai - 400 706, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.156325
|
|
|
Chronic spontaneous urticaria is a distressing disease encountered frequently in clinical practice. The current mainstay of therapy is the use of second-generation, non-sedating antihistamines. However, in patients who do not respond satisfactorily to these agents, a variety of other drugs are used. This article examines the available literature for frequently used agents including systemic corticosteroids, leukotriene receptor antagonists, dapsone, sulfasalazine, hydroxychloroquine, H2 antagonists, methotrexate, cyclosporine A, omalizumab, autologous serum therapy, and mycophenolate mofetil, with an additional focus on publications in Indian literature. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
